SCHD vs XLV
Schwab US Dividend Equity ETF vs Health Care Select Sector SPDR Fund
- • SCHD has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • SCHD pays a higher dividend yield (3.30%).
Side-by-side metrics
| Metric | SCHD | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 3.30% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $95.73B | $40.60B |
YTD return | 19.84% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.58 | 0.51 |
P/E ratio | 18.61 | 29.18 |
Last price | $32.26 | $162.17 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHD top holdings
| MRK | Merck & Co Inc | 4.52% |
| HD | The Home Depot Inc | 4.49% |
| UNH | UnitedHealth Group Inc | 4.46% |
| AMGN | Amgen Inc | 4.27% |
| ABT | Abbott Laboratories | 4.27% |
| PG | Procter & Gamble Co | 4.25% |
| KO | Coca-Cola Co | 4.21% |
| PEP | PepsiCo Inc | 3.90% |
| VZ | Verizon Communications Inc | 3.79% |
| TXN | Texas Instruments Inc | 3.71% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About SCHD
SCHD (Schwab US Dividend Equity ETF) is High-quality US dividend-paying stocks. Managed by Schwab, the fund carries $95.7B in assets under management, an expense ratio of 0.06%, a dividend yield of 3.30%. Its largest holding is Merck & Co Inc (MRK), which represents 4.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 7.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.